Skip to main content
Evidence: BSexual HealthFertility & HPG Axis

Kisspeptin-10: Benefits, Dosage & FDA Status

Kisspeptin-10 (KP-10)

A 10-amino-acid neuropeptide that triggers GnRH release. Studied as a more physiologic alternative to hCG/GnRH for fertility, libido, and HPG-axis assessment.

FDA Status

Not FDA-approved — used in clinical research as a kisspeptin/GnRH stimulus test

Typical Dose

Trial range: 0.1–10 mcg/kg IV/SC bolus

Evidence Grade

BLimited clinical + robust preclinical evidence

Half-Life

Minutes

Routes of Administration

subcutaneous, intravenous

First Synthesized

2001

Clinics Indexed

11 providers have offered Kisspeptin-10 in our tracked directory.

Mechanism of Action

Activates KISS1R on GnRH neurons, stimulating endogenous GnRH and downstream LH/FSH release.

Key Reported Benefits

Benefits listed reflect commonly reported effects from clinical trials and practitioner use. Individual response varies. Evidence-grade B indicates limited clinical + robust preclinical evidence.

Reported Side Effects

  • Generally well-tolerated
  • Transient flushing

Contraindications

  • Pregnancy

Regulatory & Safety Context

FDA status: Not FDA-approved — used in clinical research as a kisspeptin/GnRH stimulus test

This page is for educational purposes only and does not constitute medical advice. Peptide use outside of an FDA-approved indication should be discussed with a licensed medical professional. Source quality, cold-chain storage, and injection hygiene all materially affect safety outcomes.

See state-by-state legality: US peptide legality by state →

References

Selected primary literature on Kisspeptin-10. Full PubMed records linked. Additional citations are available on request.

  1. PubMed PMID 26183403

Last reviewed: 2026-04-30

← Back to all peptides